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Abstract
The nucleolus is the major site for synthesis of ribosomes, complex molecular machines that are responsible for protein
synthesis. A wealth of research over the past 20 years has clearly indicated that both quantitative and qualitative alterations
in ribosome biogenesis can drive the malignant phenotype via dysregulation of protein synthesis. However, numerous recent
proteomic, genomic, and functional studies have implicated the nucleolus in the regulation of processes that are unrelated to
ribosome biogenesis, including DNA-damage response, maintenance of genome stability and its spatial organization,
epigenetic regulation, cell-cycle control, stress responses, senescence, global gene expression, as well as assembly or
maturation of various ribonucleoprotein particles. In this review, the focus will be on features of rDNA genes, which make
them highly vulnerable to DNA damage and intra- and interchromosomal recombination as well as built-in mechanisms that
prevent and repair rDNA damage, and how dysregulation of this interplay affects genome-wide DNA stability, gene
expression and the balance between euchromatin and heterochromatin. We will also present the most recent insights into
how malfunction of these cellular processes may be a central driving force of human malignancies, and propose a promising
new therapeutic approach for the treatment of cancer.
Introduction
The nucleolus is the most prominent nuclear substructure
involved in production of ribosomes, large and complex
ribonucleoprotein machines responsible for translation of
mRNAs into proteins (Fig. 1a) [1]. The human 80 S ribo-
some is composed of a 40 S subunit consisting of 18 S
ribosomal RNA (rRNA) and 33 distinct ribosomal proteins
(RPs), and a 60 S subunit containing 5 S, 5.8 S, and 28 S
rRNAs and 47 distinct RPs [2, 3]. Nucleoli form around the
nucleolar organizer regions (NORs) on acrocentric chro-
mosomes 13, 14, 15, 21, and 22 that contain clusters of ~
300 ribosomal DNA gene repeats (rDNA) mostly arranged
in a head-to-tail manner, although inverted rDNA repeats or
palindromes are also present [4]. The number of rDNA
repeat units varies signiﬁcantly across the human popula-
tion, suggesting that these loci are susceptible to intrinsic
recombinational instability [5]. The rDNA clusters consist
of modules of ~ 13 kb transcribed by RNA polymerase I
(Pol I) into the 47 S pre-rRNA, and an intergenic spacer
(IGS) of ~ 30 kb (Fig. 1b). The 47 S pre-rRNA transcript is
processed into 18 S, 5.8 S, and 28 S rRNAs. The IGS con-
tains: spacer promoters, repetitive enhancer elements, the
47 S pre-RNA promoter, origins of DNA replication, ter-
minator elements (T) downstream and upstream of the pre-
rRNA transcription unit that can bind transcription termi-
nation factor (TTF-I), replication fork barriers (RFBs),
tandem repeats and non-coding RNA genes transcribed by
Pol II under certain stress conditions (Fig. 1b) [6]. DNA
sequences proximal and distal to rDNA arrays are highly
conserved among the ﬁve acrocentric chromosomes.
Whereas proximal sequences, termed proximal junctions
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(PJ) are segmentally duplicated and resemble the regions
ﬂanking centromeres on other chromosomes, the distal
junctions (DJ) are unique to the ﬁve acrocentric chromo-
somes and contain a large inverted repeat and 48-bp satellite
repeats (Fig. 1b) [7]. Each arm of the inverted repeat can be
transcribed by Pol II into long non-coding RNAs implicated
in chromatin regulation [7].
In proliferating cells, the nucleolus disassembles during
prophase and begins to reassemble in telophase [1].
Upstream binding factor (UBF)-dependent mitotic
Fig. 1 Nucleolus and rDNA genes. a Intranucleolar heterochromatic
inactive rDNA repeats are tightly connected with perinucleolar het-
erochromatin, whereas euchromatic active rDNA genes are transcribed
into the 47 S pre-rRNA by Pol I. The 47 S pre-rRNA is co-
transcriptionally assembled into the 90 S processome with RPs and
5 S rRNA and modiﬁed by ~200 snoRNPs. Following cleavage of the
pre-rRNA, the 90 S processome separates into a pre-60S subunit and a
pre-40S subunit that largely follow independent maturation pathways
in the nucleolus, the nucleoplasm and the cytoplasm. Modiﬁcations of
rRNA are indicated with lollipops. b Schematic diagram of the rDNA
array. Shown are coding regions for 18 S, 5.8 S, and 28 S rRNA as
well as IGS with the rDNA core promoter and upstream control ele-
ment (UCE), enhancers, spacer promoter, and Pol I promoter, ORIs as
well as T0 that binds TTF-I and T1, T4, and T5 that act as RFBs. DJ
and PJ sequences that ﬂank the rDNA array are indicated
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bookmarking of NORs is responsible for the open chro-
matin state, visible as achromatic gaps on DAPI-stained
metaphase chromosomes and the establishment of a tran-
scriptionally active state essential for post-mitotic nucleolar
formation [8]. Conversely, NORs unbound by UBF possess
epigenetic features characteristic of constitutive hetero-
chromatin; they are transcriptionally incompetent and not
associated with the nucleoli (Fig. 1a) [4]. Importantly, both
transcriptionally active (euchromatic) and inactive (hetero-
chromatic) rDNA repeats are present in “active” NORs
associated with the nucleoli (Fig. 1a) [4]. Transcriptionally
active rDNA genes represent ~ 50% of all rDNA repeats
and localize at the surface of the so-called ﬁbrillar center
where they are transcribed by Pol I into the 47 S pre-rRNA.
Inactive rDNA repeats form intranucleolar heterochromatin
[9]. The ratio between active and inactive rDNA genes is
regulated through recruitment of either Cockayne syndrome
B protein (CSB) or nucleolar remodeling complex (NoRC)
to TTF-I bound to the promoter-proximal terminator T0
[10]. Whereas the CSB-loaded TTF-I recruits histone
methyltransferase G9a and HP1γ, leading to the establish-
ment and maintenance of transcriptionally active state,
binding of NoRC subunit TIP5 (TTF-I-interacting protein 5)
to TTF-I leads to recruitment of enzymes that induce CpG
DNA methylation and heterochromatic histone modiﬁca-
tions on rDNA. However, the molecular mechanisms
responsible for the differential recruitment of CBS or NoRC
to TTF-I at T0 remain unknown [10]. Intranucleolar het-
erochromatin containing inactive rDNA repeats is tightly
connected with a shell of heterochromatin surrounding the
nucleolus, known as perinucleolar heterochromatin (Fig. 1a)
[9]. The establishment and maintenance of perinucleolar
heterochromatin is also regulated by NoRC, suggesting
functional interdependence between these two heterochro-
matic domains [11], partly mediated by the DJ sequences
embedded in adjacent perinucleolar chromatin to anchor the
NORs to nucleoli [7].
Ribosome biogenesis is the most energy consuming
process in human cells [12]. rDNA genes are the most
actively transcribed genes, collectively accounting for more
than half of total transcription in proliferating cells [13]. The
production of the 47 S pre-rRNA was thought to be exclu-
sively controlled by changing the rate of Pol I transcription.
However, recent evidence indicates that epigenetic
mechanisms also regulate this process by altering the ratio
of active and inactive rDNA genes in response to speciﬁc
cues [6, 14, 15]. The 47 S pre-rRNA is co-transcriptionally
assembled into the 90 S processome, with numerous RPs
and 5 S rRNA synthesized by Pol III, where it is subjected
to ribose 2′-O-methylation and pseudouridylation, folding
and processing steps depending on ∼200 snoRNAs (Fig. 1a)
[16, 17]. Following cleavage within the internal transcribed
spacer the 90 S processomes are separated into pre-40S and
pre-60S ribosomal subunits that follow largely independent
maturation pathways in the nucleolus, the nucleoplasm and
the cytoplasm (Fig. 1a) [18]. Most research on the nucleolus
has focused on understanding ribosome biogenesis and the
impact of altered ribosome biogenesis on the development
of human diseases, notably ribosomopathies and cancer
[19]. However, proteomic studies have identiﬁed some
4500 nucleolar proteins, mostly participating in processes
unrelated to ribosome biogenesis [20]. Based on results of
these and functional studies, the nucleolus has been impli-
cated in the regulation of additional cellular processes:
genome integrity maintenance, epigenetic control, cell-cycle
regulation, diverse stress responses, cellular senescence,
genomic organization, nuclear architecture, and maturation,
assembly, and export of the signal recognition particle,
telomerase RNP and processing of precursor transfer RNAs
[19, 21]. Collectively these studies demonstrate that the
nucleolus performs many more functions than originally
appreciated.
Several features make rDNA genes highly vulnerable to
DNA damage and intra- and interchromosomal recombi-
nation, including high transcription rate, challenging DNA
replication, repetitive nature, and presence in clusters on
ﬁve different chromosomes [4, 22]. This review will discuss
rDNA damage and repair mechanisms, and how dysregu-
lation of these processes affects genome-wide DNA stabi-
lity, gene expression and the balance between euchromatin
and heterochromatin. We will also review the recent
advances in understanding how malfunction of these pro-
cesses may contribute to malignancy, and opportunities to
exploit this emerging knowledge for improvements of
anticancer treatments.
Systematic proteomic and genomic studies
implicate the nucleolus in promoting
genome stability
Based on studies of the nucleolar proteome and the human
protein atlas database, Ogawa and Baserga assembled a list
of 166 DNA repair proteins that localize to the nucleolus
[23]. However, whether the nucleolus is just a storage depot
for DNA-damage response (DDR) proteins that operate in
the nucleus or they indeed play some speciﬁc nucleolar
roles, remains unclear. A number of DDR proteins accu-
mulate in the intranucleolar body (INB) and nucleolar cap
structures upon DNA damage, suggesting that these struc-
tures provide a platform for recruitment of speciﬁc factors
that sense and repair rDNA damage in the nucleolus [24].
Furthermore, genetic screens to identify human ribosome
biogenesis factors revealed that a subset of these factors are
co-classiﬁed as DDR proteins [25–27]. Moreover, a mass
spectrometry analysis of proteins phosphorylated in
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response to DNA damage by ataxia-telangiectasia-mutated
(ATM) and ataxia telangiectasia and Rad3-related (ATR)
kinases revealed 700 target proteins, 98 of which are
nucleolar proteins involved in various aspects of ribosome
biogenesis, ribosome function and epigenetic regulation of
rDNA genes, thus further supporting the notion that the
nucleolus is an important hub of the DDR [28, 29]. A recent
genetic screen in yeast revealed that almost 15% of 4876
non-essential genes, most of which have not been linked to
nucleolar functions so far, are required for the maintenance
of rDNA stability, revealing an unexpected complexity of
this process. Lastly, in HeLa and HT1080 cells, ~ 4% of the
genome, including tandemly arrayed genes, tRNAs, highly
repetitive centromeric, pericentromeric, telomeric, and
satellite sequences are embedded in the perinucleolar het-
erochromatin [30, 31]. The close proximity between the
nucleolus and these so-called nucleolus-associated chro-
mosomal domains further suggests a role for the nucleolus
in spatial genome organization. Altogether, these systematic
approaches provide a wealth of information that can serve
as a strong foundation for future mechanistic studies to
elucidate the interplay between the nucleolus, the DDR,
chromatin and spatial genome organization in the main-
tenance of genome stability and cancer prevention.
Conﬂicts between replication and
transcription machineries at the rDNA genes
as a source of genomic instability
Mounting evidence indicates that DNA replication
machinery frequently encounters obstacles, which can slow
down or stall replication fork progression, leading to DNA
damage and recombination. Insults causing such replication
stress (RS) include: DNA secondary structures, hetero-
chromatin, DNA lesions, torsional stress in DNA, tightly
DNA-bound proteins and transcribed genes [32, 33]. The
transcriptional machinery presents a particularly severe
impediment to DNA replication, and clashes between these
two molecular machineries represent the major source of
genomic instability, an event fueling the acquisition of all
cancer hallmarks [34–37]. Given that rDNA genes are the
most highly transcribed genes in eukaryotes, conﬂicts
between transcription and replication are especially frequent
at rDNA gene clusters [38]. To better understand how
conﬂicts between rDNA transcription and replication
machineries occur and how they contribute to genome
instability, we will ﬁrst brieﬂy describe what is known
about the causes and consequences of these conﬂicts at the
other genomic regions [39].
Head-on convergence between DNA replication forks
and transcription machineries may trigger local accumula-
tion of positive DNA supercoils, which likely block
replication fork progression, leading to fork slowing and
stalling [37, 40]. Such persistent fork stalling can lead to
occurrence of long stretches of single-stranded DNA
(ssDNA) and single-strand DNA breaks (SSBs), events
which trigger a checkpoint surveillance program orche-
strated by the ATR-Chk1 kinase signaling module [41–43].
These kinases phosphorylate many factors that function to
prevent genome instability by: stabilizing the replication
fork, release of RNA polymerase and termination of tran-
scription, activating dormant origins of replication around
the stalled forks to facilitate the replication of affected
regions, blocking late origin activation, orchestrating DNA
repair with restart of stalled forks and cell-cycle inhibition
[28, 32, 44]. Under persistent RS or when the ATR-
dependent RS-response fails, stalled forks may collapse,
leading to dissociation of replisome proteins and conversion
of SSBs into double-strand breaks (DSBs), the most dele-
terious of DNA lesions [32]. DSBs trigger activation of the
ATM kinase, which orchestrates cell-cycle arrest and DSB
repair. If repair is successful, DNA replication resumes [45,
46]. However, when the ATR checkpoint is malfunctional
and/or error-prone DNA repair processes are engaged,
various genomic alterations may result from RS, including:
point mutations, deletions or ampliﬁcations, loss of het-
erozygosity, gross chromosomal rearrangements, and
structural and numerical chromosomal aberrations if unre-
plicated DNA or unresolved repair intermediates persist
until mitosis [32, 47].
Recent studies suggest that genomic instability upon
clashes of transcriptional and replication machineries
depends on transcription-associated R-loop formation [48–
51]. R-loops form owing to local negative supercoiling
behind a transcription bubble, followed by opening of the
DNA and formation of highly stable hybrids between nas-
cent RNA and template DNA strands (RNA:DNA hybrid)
[48, 49]. The overall load of R-loops increases under per-
turbed replication and fuels DNA damage and genomic
instability (Fig. 2) [34, 52]. Persistent R-loops can also
impede RNA Pol elongation, resulting in the pileup of Pol
molecules, ultimately provoking replication fork slowing
and stalling [50, 53]. The number and length of R-loops
increase upon dysregulation of post-transcriptional pro-
cesses, including packaging of nascent RNAs into ribonu-
cleoprotein particles, mRNA splicing, export or
degradation, explaining the association of dysregulation of
these post-transcriptional processes and genomic instability
[49, 54]. R-loop formation is counteracted by Topoisome-
rases 1 and 2 (Top1/2), which relieve positive and negative
supercoils ahead of and behind transcribing RNA poly-
merases, respectively, DNA helicases Senataxin that
unwinds RNA:DNA hybrids, and RECQ5 that counteracts
replication fork stalling in RNA pol I and II transcribed
genes, acting at sites of replication-transcription collisions,
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and RNAse H1 which cleaves the RNA component of the
RNA:DNA hybrid [55–59]. Importantly, BRCA1 and the
Fanconi anemia pathway, that stabilize stalled replication
forks, also help resolve transcription-associated R-loops,
thus allowing continuation of DNA replication (Fig. 2) [60,
61]. Apart from directly or indirectly impairing progression
of the replication machinery and causing RS, R-loops can
also enhance genomic instability by serving as substrate for
transcription-coupled nucleotide excision repair (NER)
factors, which generate DSBs or through generation of
various types of DNA lesions in the displaced non-template
DNA strand by DNA-damaging agents, DNA modifying
and repair enzymes [48, 62–64].
Active rDNA genes are transcribed by >100 Pol I tran-
scriptional complexes [65]. This, together with the fact that
rDNA transcription occurs also in early S phase, suggests
that the Pol I transcriptional machinery may represent a
barrier for replication fork progression [1, 66–68]. How-
ever, recent research has suggested the spatial separation
between these machineries on rDNA genes in early S phase
[68, 69]. Furthermore, upon binding TTF-I and a replisome
factor timeless to RFBs in the IGS regions of the rDNA loci
obstruct replication fork progression and thereby prevent
potential clashes of transcription and replication machi-
neries (Figs. 1b and 2) [70]. The highest RFB activity is in
early S phase when actively transcribing rDNA genes
replicate [66, 70]. The rDNA region is a frequent site for R-
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Fig. 2 Causes and consequences of conﬂicts between Pol I transcrip-
tional and replication machineries. The indicated oncogenic signaling
pathways can lead an aberrant increase in the rate of Pol I transcrip-
tion. Convergence of Pol I and replication machineries in head-on
orientation leads to the accumulation of positive DNA supercoiling,
which slows down both machineries. Negative DNA supercoiling
forming behind transcription bubble leads to opening of rDNA strands
and the formation of highly stable rRNA:rDNA hybrids, leaving the
displaced non-template strand. The rDNA genes are predilection sites
for the formation of R- loops owing to the presence of a region of GC
skewing, downstream of unmethylated CpG island rDNA promoters.
Clashes of Pol I transcriptional machinery and R-loops with replication
fork may cause its stalling or collapse. Perturbing replication of rDNA
may further potentiate conﬂicts between replicating forks and Pol I
transcriptional machinery as well as generation and stabilization of co-
transcriptional R-loops and R-loop dependent rDNA damage. Several
protective and DNA repair mechanisms are shown that preserve
genome stability upon conﬂicts between Pol I transcriptional and
replication machineries, thus preventing tumorigenesis. Asterisks
indicate DNA damage
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loop formation [71], owing to an unmethylated CpG island
in rDNA promoters making the non-template strand G-rich
(Fig. 2). A G-rich pre-rRNA outcompetes a G-rich non-
template rDNA for binding to a C-rich template DNA
strand, forming a stable rRNA:rDNA hybrid. Under phy-
siological conditions, R-loop formation at rDNA promoters
prevents DNA methylation of CpG islands by DNA
methyltransferase DNMT3B1, thus facilitating rDNA tran-
scription [71]. R-loops are formed co-transcriptionally over
the Pol I promoter, the 5′ external transcribed sequence and
the 5′ region of the 18 S rDNA in yeast cells. Loss of Top1
and RNase H enhances this inherent formation of R-loops,
which then cause severe Pol I pileups and consequent
inhibition of pre-rRNA synthesis (Fig. 2) [56]. A sub-
sequent study demonstrated that RS caused by aphidicolin,
an inhibitor of replicative DNA polymerases, results in the
formation of co-transcriptional R-loops at the 5′ ends of
active human rDNA genes, and consequent DNA damage
via R-loop-dependent mechanisms (Fig. 2) [71]. This model
is further supported by experiments in which depletion of a
negative regulator of rDNA transcription, the PHD ﬁnger
protein 6 (PHF6), led to the formation R-loops and accu-
mulation of R-loop-dependent rDNA damage in human
nucleoli [72]. Mutations in the PHF6 gene have been
associated with the X-linked mental retardation disorder
Borjeson–Forssman–Lehmann syndrome as well as with
acute myeloid leukemia, T-cell acute lymphoblastic leuke-
mia and hepatocellular carcinoma, implying that R-loop-
mediated rDNA damage might contribute to the pathogen-
esis of these diverse diseases [73, 74]. Whether DSBs in
spontaneous human cancers that frequently localize to
transcriptionally active rDNA genes are generated through
this mechanism remains untested [75]. Mutations in RP
genes or ribosome biogenesis assembly factors can cause
both inherited and sporadic human cancers [16, 76]. Given
that excessive accumulation of nascent mRNAs facilitates
the R-loop formation [49, 54], it is plausible that mutations
impacting ribosome biogenesis impair pre-rRNA proces-
sing, leading to accumulation of unprocessed or partially
processed pre-rRNA (Fig. 2). This may facilitate R-loop
formation, and thereby interference with DNA replication,
rDNA damage, genomic instability, and cancer.
An important question is whether oncogenes and loss of
tumor suppressors contribute to cancer pathogenesis by
causing rDNA damage. The rate of Pol I transcription is
directly or indirectly upregulated by activation of a number
of oncogenic pathways, including Myc, PI3K-Akt-
mTORC1, Ras-MAPK, and cyclin E, the loss of tumor
suppressors such as PTEN, pRb, p53, ARF, GSK3β, or
dysregulation of factors that mediate epigenetic events at
the rDNA locus (Fig. 2) [77]. It will be critical to assess
whether dysregulation of different oncogenic pathways
generates damage at speciﬁc sites within rDNA genes,
given their differential impact on the rate of rDNA tran-
scription, DNA replication process, ROS production and the
rate of cell division (Fig. 2) [78–83]. Copies of rDNA that
replicate during mid/late S phase show compact hetero-
chromatic structure suggesting that they are difﬁcult to
replicate, particularly under conditions of RS [67]. Con-
sistently, recent work suggests that old hematopoietic stem
cells, which characteristically display RS owing to
decreased expression of the mini-chromosome maintenance
replicative helicase, feature enhanced chromosome break-
age in late-replicating, heterochromatic rDNA clusters [84].
Such aberrant replication in rDNA could lead to accumu-
lation of unreplicated or unresolved repair intermediates in
mitosis and consequently structural and numerical chro-
mosomal aberrations, as observed elsewhere in the genome
[47].
Epigenetic status of the rDNA impacts the susceptibility
of rDNA to breakage upon RS caused by folate deﬁciency,
an essential factor for nucleotide biosynthesis. Folate deﬁ-
ciency enhanced DNA damage in the whole-genome [85],
but it was particularly prominent in several speciﬁc regions
of IGSs within rDNA clusters [86]. These breaks sites
correspond to histone H3K4me1 mark sites and positively
correlate with increased recruitment of UBF to rDNA genes
and their enhanced transcription [86]. One could speculate
that DNA breakage under these conditions is the con-
sequence of clashes between transcriptional and replication
machineries [86]. Despite this recent progress, however,
mechanisms leading to rDNA damage remain poorly
understood.
Repair of rDNA
Repair of DSBs in rDNA shows some atypical features,
reﬂecting a combination of the more faithful homologous
recombination (HR) repair pathway and the more error-
prone non-homologous end-joining (NHEJ) pathway [87].
HR repair preserves rDNA stability when the rDNA tem-
plate is the sister chromatid, yet such rDNA repair can also
result in rDNA copy number alterations and genomic
rearrangements if it is mediated by unequal sister chromatid
recombination or recombination with homologous NOR-
bearing chromosomes [88]. Unequal sister chromatid
recombination may reﬂect malfunctional mechanisms that
normally restrict the movement of sister chromatids relative
to each other. For example, in yeast strains harboring low-
rDNA-copy number most rDNA copies are actively tran-
scribed, and the inability of condensin to bind tran-
scriptionally active rDNA genes interferes with cohesion
between sister chromatids at the rDNA loci, resulting in
unequal sister chromatid recombination and rDNA
instability [89]. In contrast, sufﬁcient numbers of
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heterochromatically silent rDNA repeats facilitates con-
densin association and proper sister chromatid cohesion
[89]. It is tempting to speculate that dysregulated balance
between active and inactive rDNA genes could also affect
the mode of HR at the rDNA genes in human cells via a
similar mechanism.
The critical importance of proper regulation of replica-
tion and repair at rDNA clusters for tumor suppression was
supported by studies of two human cancer-prone syn-
dromes: Ataxia telangiectasia (A–T) and Bloom syndrome,
which show 10-fold and 100-fold elevations of the rate of
spontaneous alterations in the rDNA gene cluster archi-
tecture, respectively [75, 90]. A-T is caused by mutations in
the ATM gene, the kinase product of which orchestrates
DSB repair by HR, whereas Bloom syndrome is caused by
mutations in the BLM gene encoding a helicase critical for
the dissolution of Holliday junctions and abortive HR
intermediates, structures that facilitate exchange of chro-
mosome segments between sister chromatids or homo-
logous chromosomes [91, 92]. rDNA gene clusters are also
recombinatorial hot spots in human cancers, with over 50%
of lung and colorectal carcinomas showing rDNA rearran-
gements [75, 93]. Furthermore, genomic rearrangements
involving rDNA, including insertions, ampliﬁcations, and
jumping translocations occur frequently in Hodgkin’s lym-
phoma [94]. These observations indicate that the genomic
rearrangements are positively selected for during tumor
evolution and that the maintenance of rDNA stability may
represent a major tumor-suppressive mechanism.
Notably, besides endogenous rDNA damage, rDNA
recombination in human cancer may also reﬂect exogen-
ously caused DNA damage, a notion consistent with the
higher frequency of rDNA alterations in adult solid cancers
compared with pediatric cancers [75]. Given that a small
proportion of rDNA genes are arranged as inverted (palin-
dromic) repeats, intermolecular recombination between
such repeats on the various acrocentric chromosomes might
generate dicentric chromosomal translocations linked by an
rDNA cluster, somewhat reminiscent of the Robertsonian
translocations [7]. It can also be hypothesized that the
almost complete nucleotide sequence identity of DJ and PJ
sequences surrounding rDNA clusters on acrocentric chro-
mosomes, could predispose these regions as sites of
recombination involving these chromosomes [7]. However,
direct experimental evidence in support of these hypotheses
is still lacking. As discussed above, illegitimate junctions of
broken DNA ends during inappropriate DNA repair events
may also result in rDNA copy number alterations [88, 95].
The impact of dysregulated rDNA copy
number in cancer
It is plausible that more copies of rDNA genes may confer
upon incipient cancer cells a competitive advantage over
untransformed cells by providing an increased capacity for
ribosome biogenesis and proteosynthesis [96]. Although
this may occur in some tumors, recent studies identiﬁed
lower rDNA copy numbers in several human cancer types
compared with adjacent normal tissues [97, 98]. Interest-
ingly, deletion of the mTORC1 negative regulator, tumor
suppressor PTEN, in hematopoietic stem cells resulted in a
lower rDNA copy number, which preceded their malignant
transformation. Notably, these cells showed increased rates
of rDNA transcription, proteosynthesis and proliferation,
suggesting a compensatory increase in transcriptional
activity of the remaining rDNA genes [97]. Furthermore,
the ﬁnding that speciﬁc cancer types harboring lower rDNA
copy number show mutational activation of mTORC1,
suggests that increased mTORC1 activity might fuel rDNA
damage and consequent inappropriate recombination and
loss of rDNA copies, likely via mTORC1-dependent
Table 1 Inappropriate rDNA
repair may lead to chromosomal
rearrangements that contribute to
cancer
Chromosomal rearrangements involving rDNA Consequences
rDNA gain Increased ribosome biogenesis
Collision between Pol I transcription and replication
machineries
rDNA loss Increased transcription of the remaining rDNA genes
Loss of nucleolar heterochromatin
Alteration of the global epigenetic landscape
Centromeric, pericentromeric and telomeric instability
Altered condensin-dependent DNA repair
Genome-wide dysregulation of gene expression
Faster replication of the genome
Increased sensitivity to DNA-damaging agents
Translocations (dicentrinc, multiple jumping) Unknown
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upregulation of rDNA transcription [97, 99]. Consistent
with such model, hyperactivation of mTOR in Drosophila
melanogaster by mutations in components of the insulin/
mTOR signaling axis or excessive nutrient uptake instigated
loss of rDNA copies [100]. Mutations in the TP53 gene
have also been positively correlated with decreased rDNA
copy numbers in several cancer types [98].
These studies provoke the question: how would cancer
cells beneﬁt from a decrease in rDNA copy number? A
lower rDNA copy number could potentially decrease rDNA
heterochromatin levels and alter the balance of nuclear
heterochromatin/euchromatin, increase transcription of the
remaining rDNA genes, dysregulate gene expression
genome-wide and promote illegitimate recombination
between highly repetitive DNA sequences (Table 1) [89,
101, 102]. Any or all of these features may explain why the
rDNA loss could be positively selected for during cancer
evolution [97]. Furthermore, mutations of genes required
for heterochromatin formation in Drosophila and human
cells led to decreased rDNA copy numbers and promoted
global genome instability [11, 103]. These studies under-
score the intimate link between rDNA copy number, global
heterochromatin, and regulation of genome stability, with
important implications for cancer pathogenesis. An addi-
tional explanation for how would cancer cells beneﬁt from
decreased rDNA copy numbers is that the loss of hetero-
chromatic rDNA genes, which are hard-to-replicate, may
allow faster replication of the genome, thereby providing
the incipient cancer cells with a growth advantage (Table 1)
[67, 97].
Ample evidence implicates dysregulated insulin/
mTORC1 signaling and TP53 mutations in cancer patho-
genesis [104–108]. Indeed, decreased rDNA copy number
may contribute to tumorigenesis driven via increased insu-
lin/mTOR signaling activity or TP53 aberrations [97, 98].
However, lower rDNA copy numbers may be necessary but
not sufﬁcient to drive cancer or they may be just a con-
sequence of malignant transformation. These possibilities
are consistent with the observation that many healthy
individuals harbor low-rDNA copy number [97, 109].
p53 activation
Cell cycle arrest
Apoptosis
Senescence
IRBC
NPM1
NCL
ARF
Nucleus
Nucleolus
Pol I transcription
inhibition
ATM
ATR
ATM
ATM rDNA
1
1
2
3
Pol I
DJ
HR 
factors
NHEJ
factors
Cdc14B
Cdc14B
APC/Ccdh1
Plk1
G2 cell cycle 
checkpoint
NBS1
MDC1
Fig. 3 Nucleolar response to nuclear or nucleolar DNA damage. DSBs
in the nuclear chromatin cause Pol I inhibition in the nucleolus through
an ATM-dependent signaling pathway, which includes NBS1, PARP,
and Treacle. Pol I is also inhibited upon direct rDNA damage in an
ATM-NBS1-MDC1-dependent manner. Inhibition of Pol I transcrip-
tion is most likely responsible for the formation of nucleolar caps and
relocalization of damaged rDNA to this structures, which are enriched
in HR and NHEJ factors, thus providing an optimal environment for
proper rDNA repair. Notably, cap formation was not observed upon
nuclear DNA damage is several studies, in spite of Pol I inhibition.
DDR and associated Pol I inhibition activate p53 through the impaired
ribosome biogenesis checkpoint (IRBC), NMP1, NCL, ARF, ATM,
and ATR. Upon genotoxic stress, Cdc14B is released from the
nucleolus to the nucleoplasm where it promotes APC/CCdh1-dependent
Plk1 degradation, triggering a G2-phase cell-cycle checkpoint. Aster-
isks indicate DSBs
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DDR coordinates Pol I inhibition with rDNA
repair
DDR signaling regulates multiple cellular activities,
including inhibition of Pol I transcriptional activity (Fig. 3)
[29], and promotion of nucleolar cap formation with
recruited DNA repair factors, thereby preventing collisions
with DNA repair machineries and providing an optimal
environment for rDNA repair [29, 110, 111]. Two modes of
DSB-induced Pol I transcriptional inhibition depend on
ATM [29]. First, signaling from ionizing radiation (IR)-
induced DSBs transiently represses rDNA transcription via
ATM, Nijmegen breakage syndrome 1 (NBS1) and med-
iator of DNA-damage checkpoint protein 1 (MDC1) (Fig. 3)
[112], accompanied by segregation of the nucleolar protein
UBF into nucleolar caps. When DSBs were locally intro-
duced using laser micro-irradiation in individual nucleoli,
inhibition of rDNA transcription did not spread to sur-
rounding nucleoli. Inhibition of Pol I was absent in ATM-
null murine ﬁbroblasts, NBS1- or MDC1-depleted cells
upon IR [112]. Molecularly, the ATM-NBS1-MDC1 sig-
naling interfered with Pol I initiation complex assembly
followed by displacement of the elongating Pol I holoen-
zymes from rDNA [112]. Second, more recent studies
described how inhibition of Pol I transcription occurs in
response to DSBs introduced in chromatin outside the
nucleoli (Fig. 3) [110, 113, 114]. This response featured
ATM-dependent accumulation of NBS1 speciﬁcally in
actively transcribed nucleolar regions of rDNA, temporally
correlating with inhibition of rDNA transcription [114]. In
this setting, inhibition of rDNA transcription occurred in all
nucleoli of a cell even when DSBs were introduced outside
of the nucleoli. Mechanistically, NBS1 recruitment into the
nucleoli required interaction with the nucleolar protein
Treacle (encoded by the TCOF1 gene), but not the usual
NBS1 partner, MRE11 (Fig. 3) [114].
Pol I activity can also be inhibited upon DNA damage in
DNA-PK- and PARP-1-dependent manner [115]. Finally,
the proteins TopBP1 and ATR also co-operate to inhibit
pre-rRNA synthesis upon DNA damage and RS [116].
Collectively, available data suggest roles for ATM, ATR,
and DNA-PK kinases in downregulation of rDNA tran-
scription following DNA damage.
Where and how are DSBs in rDNA repaired in mam-
malian cells? Induction of DSBs within the rDNA repeats
by either CRISPR-cas9 technology or I-PpoI expression
resulted in nucleolar cap formation and downregulation of
Pol I transcription in an ATM-dependent manner (Fig. 3)
[110, 111]. Damaged rDNA moves from the nucleolar
interior to the periphery where it is accessible to DNA repair
factors (Fig. 3). NHEJ was the predominant mode of DSB
repair [110] but DSBs within rDNA may also recruit the HR
machinery throughout the cell cycle (Fig. 3) [95, 111].
DNA synthesis indicative of HR at damaged NORs was
observed in G1 suggesting that damaged rDNA that cannot
be re-joined by NHEJ factors is recognized and repaired by
the HR machinery at the nucleolar periphery (Fig. 3) [111].
Chromosomal context may impact nuclear DSB signaling to
nucleoli, as DSBs in the distal junction, a genomic sequence
immediately distal to the rDNA arrays, did not inhibit
rDNA transcription [111].
There are several putative nucleolar ATM targets of
relevance for rDNA silencing, including Pol I subunits
RPA34 and TAF1C [29]. PHF6 is another candidate ATM
substrate, known to interact with UBF at the rDNA pro-
moter region [29]. The importance of these ATM-dependent
mechanisms is apparent in cells from A-T patients, which
show a 10-fold increase in spontaneous rDNA alterations
over normal cells [75, 90]. One can also speculate that a
failure to mount these protective DDR responses in cancer
cells may increase their vulnerability to genotoxic
treatments.
Nucleolar stress responses triggered by DNA
damage and oncogenic stress
The nucleolus responds to different types of DNA damage
and oncogenic stressors by activating diverse signaling
pathways that affect cell-cycle progression in both p53-
dependent and -independent manners, trigger cellular
senescence and promote DNA repair [117]. It is well
established that upon impairment of ribosome biogenesis
RPL11 (uL5) and RPL5 (uL18), trigger p53 activation [16,
118–124]. RPL11 and RPL5 activate p53 as constituents of
the 5 S ribonucleoprotein particle that also contains 5 S
rRNA [124–126]. This response was recently termed the
Impaired Ribosome Biogenesis Checkpoint (IRBC) [127].
Mechanisticly, impairment of any step of ribosome bio-
genesis leads to redirection of the nascent IRBC from the
assembly into pre-60S ribosomes towards inhibition of
MDM2, the E3 ligase that negatively regulates p53 [124–
126]. DDR signaling often converges on the inhibition of
rDNA transcription, which may trigger activation of p53 by
the IRBC-dependent mechanism (Fig. 3) [19]. In addition,
oncogenic stresses also trigger the IRBC-mediated cellular
senescence by enhancing rDNA transcription and delaying
rRNA processing, further highlighting the complexity of the
nucleolar stress signaling [128]. However, further research
should uncover the role(s) of the IRBC-mediated mechan-
isms in cancer pathogenesis caused by DNA-damaging and
oncogenic stressors.
In addition to the IRBC, DNA damage triggeres addi-
tional nucleolar signaling pathways, which may or may not
co-operate with the IRBC in p53 activation (Fig. 3). For
example, the protein interacting with carboxyl terminus 1
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regulates the IRBC via interaction with RPL11 under
impaired ribosome biogenesis [129] but also links ATM
signaling to the IRBC upon DNA damage [130].
The tumor suppressor protein ARF acts as key activator
of the p53 stress signaling pathway by inhibiting MDM2 in
response to oncogene activation but is also involved in
controlling nucleolar structure and limiting protein synth-
esis (Fig. 3) [131, 132]. Despite it was originally suggested
that the ARF-MDM2 and IRBC-MDM2 pathways are dis-
tinct, it appears that the IRBC also sets the level of p53
activation by ARF [125].
The abundant nucleolar protein nucleophosmin (NPM1)
interacts constitutively with ARF, sequestering it in the
nucleolus [133]. Upon genotoxic stress, modiﬁcations of
NPM1 lead to the release of ARF which then translocates to
the nucleoplasm, where it inhibits MDM2. Notably, NPM1
directly binds MDM2 and p53 to regulate the MDM2-p53
pathway in an ARF-independent manner. For example, UV
damage triggers NPM1 translocation from the nucleolus to
the nucleoplasm where NPM1–MDM2 complexes are
formed [134]. Interestingly, NPM1–ARF interaction may
have an important role upon DNA damage in the absence of
ATM. Active ATM phosphorylates protein phosphatase 1,
which dephosphorylates NPM1 in the nucleolus, thereby
weakening the binding between ARF and NPM1 [135].
This allows ARF to translocate to the nucleus where it is
degraded by the ubiquitin ligase of ARF (ULF) [135]. In
contrast, ATM loss promotes ARF accumulation, which
may activate p53 and inhibit ribosome biogenesis, acting as
a potential tumor suppressor back-up mechanism following
DNA damage in cells with compromised ATM function.
Several other examples of the interplay between NPM1
and DDR mechanisms, particularly DNA repair pathways,
have been identiﬁed. NPM1 is essential for embryonic
development and its loss was associated with DNA damage
and genome instability [136, 137]. Interestingly, NPM1 co-
localizes with γH2AX following γ-irradiation (IR) and
contributes to DSB repair [138]. NPM1 phosphorylated at
residue Thr199 is recruited to IR-induced DSBs through
K63-linked ubiquitination mediated by RNF8/RNF168
[138]. Furthermore, NPM1 is involved in DNA repair of
ssDNA lesions by BER and NER repair pathways, reviewed
in ref139. Similar to NPM1, another abundant nucleolar
protein, nucleolin (NCL), associates with a number of DDR
proteins near DSBs [140]. Reduced levels of NCL nega-
tively affect accumulation of speciﬁc DDR proteins, DSB
repair and weaken ATM-dependent cell-cycle checkpoints
[140]. Analogous to NPM1, NCL interacts with MDM2,
disrupting its association with p53 [141]. Furthermore, NCL
binds both 5′ and 3′-UTR of p53 mRNA to repress its
translation, but is outcompeted by ribosomal protein RPL26
following IR to boost p53 mRNA translation [142]. Other
molecular interactions between NCL and the DDR
machinery have been reviewed elsewhere [143]. Whether
NPM1 and NCL are also involved in sensing and repair of
potential rDNA damage and/or in sensing defective pre-
rRNA processing remains to be determined.
Furthermore, dual speciﬁcity phosphatase cell division
cycle 14B is also released from the nucleolus upon geno-
toxic stress to dephosphorylate and activate the anaphase-
promoting complex/cyclosome/(APC/CCdh1) ubiquitin
ligase in the nucleoplasm, leading to polo-like kinase
degradation, and the consequent execution of a G2-phase
cell-cycle checkpoint [144].
On the other hand, several signaling pathways previously
linked to DNA damage are activated in cells upon speciﬁc
impairments of ribosome biogenesis. The most convincing
evidence so far points to activation of the ATR-Chk1-
dependent G2/M cell-cycle checkpoint pathway in cells
treated with low concentrations of actinomycin D, which
speciﬁcally inhibits Pol I activity [145]. Additional studies
showed that both the ATR-Chk1 and ATM-Chk2 signaling
pathways are active in RP-deﬁcient cells, for example in
RPS19-depleted cells [146]. What could be the trigger for
activation of these canonical DDR pathways under such
conditions? The accumulation of pre-rRNA upon pre-rRNA
processing defects may facilitate the formation of R-loops,
leading to DNA RS and rDNA damage as discussed in
Section 3 [147]. Moreover, the increased demand for rRNA
in RP-deﬁcient cells could lead to compensatory transcrip-
tional activation of silent rDNA genes, with the ensuing
DNA topological stress, R-loop formation and rDNA
damage [147]. Finally, an imbalance in nucleotide pools
owing to defects in pre-rRNA synthesis may also cause
DNA RS and activation of the ATR/Chk1-signaling path-
way [146].
In view of the extensive interaction between DDR and
ribosome biogenesis it comes as no surprise that their
functions are dysregulated in many cancer types and that the
mechanism of action of many DNA-damaging chemother-
apeutics used for cancer treatment involves either the inhi-
bition of pre-rRNA synthesis or its maturation in both
DDR-dependent and -independent manners [16, 19, 148].
However, the relative contribution of these ribosome bio-
genesis impairments to their anticancer efﬁcacy still remains
to be determined.
Role of the nucleolus in chromatin and
genome organization
In addition to a decrease in rDNA copy number, disruption
of the heterochromatin architecture surrounding nucleoli is
seen in cells depleted of speciﬁc RPs, indicating that
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alterations of the ﬁne balance between ribosome biogenesis
and chromatin organization could be an unanticipated
mechanism by which RP-deﬁciencies mediate pathological
phenotypes [76, 149].
Different protein complexes, in part through association
with RNA genes transcribed by RNA pol III (5 S rRNA,
tRNA), and RNA species (e.g., long non-coding RNA) may
be involved in the establishment and maintenance of
nucleolus-chromatin domain interactions. One nucleolus-
chromatin tethering candidate is CCCTC-binding factor
(CTCF), a sequence-speciﬁc DNA binding protein that acts
as a transcriptional repressor, and delimits juxtaposed
domains of active and inactive chromatin [150]. CTCF loss
in HeLa cells resulted in nucleolar fragmentation and
reduced rDNA silencing [151]. Similarly, in Drosophila
cells, CTCF loss resulted in nucleolar fragmentation and
activation of silent rDNA [152].
Some members of the nucleoplasmin/NPM1 family of
histone chaperones [153] including NPM1, NPM2, and
dNLP share the nucleolar localization and various nucleolar
activities. In a landmark paper, the Drosophila
nucleoplasmin-like protein (dNLP), CTCF, and the
nucleolar protein Modulo (homolog of mammalian NCL),
proved to be essential for the positioning of centromeres
near the nucleolus [154]. Centromere clustering during
interphase occur in different organisms and cell types, and
often around the nucleolus. dNLP and CTCF were sufﬁcient
for clustering, whereas Modulo served as the nucleolar
anchor. Interestingly, in this case, unclustering of cen-
tromeres resulted in spatial destabilization of pericentric
heterochromatin, partial defects in the silencing of repetitive
elements, defects during chromosome segregation, and
subsequent genome instability [154]. Of particular interest
is that NPM1 also interacts with CTCF in mammalian cells
and may function in a similar fashion [150].
Another example comes from studies on the mammalian
maternal oocyte nucleolus, a structure essential for early
embryonic development in mammals [155, 156]. Zygotes
derived from enucleolated oocytes exhibit abnormal het-
erochromatin formation around parental pericentromeric
DNA, causing mitotic delay and frequent chromosome mis-
segregation in the ﬁrst mitotic division [156]. It is well
known that the mouse nucleoplasmin-like protein Npm2
accumulates in oocyte nuclei and nucleoli, and its persis-
tence there in preimplantation embryos is critical for
nucleolar formation and embryonic development [157].
Npm2-deﬁcient oocytes lack normal nucleolar structure, not
being surrounded by heterochromatin, and display chro-
mosome segregation defects similar to those in enucleolated
oocytes [156]. Remarkably, expression of Npm2 alone was
sufﬁcient to reconstitute the nucleolar structure in enu-
cleolated embryos and rescued the ﬁrst mitotic division and
full-term development [156].
Interestingly, the nucleolar phenotype in NPM1-depleted
cells displays similarities to that observed in Npm2-
deﬁcient oocytes [158]. Moreover, cells derived from
Npm1 knockout mice exhibit extensive genome instability
and mitotic defects in analogy with Npm2 [158]. Chronic
and acute NPM1 loss disrupts normal nucleolar morphology
and triggers rearrangement of perinucleolar heterochromatin
indicating a function of NPM1 in the spatial organization of
nucleolus-associated heterochromatin similar to NPM2
[159].
All together, these ﬁndings further highlight the impor-
tance of the nucleolus as a platform for the organization of
chromatin and regulation of genomic stability.
Conclusions
Intense research efforts over the last decade have suggested
that the maintenance of rDNA stability is critical for normal
structure and functions of the nucleoli but also for genome
maintenance, global chromatin regulation, and genome-
wide gene expression. It is also becoming evident that
instability of rDNA gene clusters may be an early event in
tumorigenesis and a driving force in human cancer. Quan-
tiﬁcation of rDNA copy number could be used in the future
to gain a more precise insight into the extent of rDNA copy
number variations in various cancer types [97]. Similar to
yeast, the loss of rDNA copies increases the sensitivity of
cancer cells to DNA-damaging agents (Table 1) [89, 97].
Thus, rDNA copy number could be a cancer patient strati-
ﬁcation marker to guide genotoxic therapies. The observa-
tions that almost 10% of yeast genes are involved in the
maintenance rDNA stability suggests that the mechanisms
contributing to rDNA instability described in this review are
most likely just the tip of the iceberg [160]. These genes are
involved in numerous cellular processes including DNA
repair, DNA metabolic processes, epigenetic regulation,
transcription, amino-acid transport, protein modiﬁcations,
ribosome biogenesis, protein synthesis, and regulation of
cell cycle. Addressing roles of the human homologs of these
genes in genome maintenance and cancer pathogenesis may
be another fruitful avenue for future investigations. Given
the observation that upregulation of mTOR activity by
excessive nutrient uptake in D. melanogaster instigated loss
of rDNA copies [100], future studies of this phenomenon
are warranted in humans, particularly because the well
documented links between overnutrition, obesity, high
insulin levels and dyregulation of the mTORC1-signaling
pathway with the pathogenesis of cancer [104–107]. Taken
together, future studies on the role of the nucleolus in the
regulation of genome stability could have huge implications
for anticancer therapies as well as cancer prevention
measures.
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